Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 24.26 is 480% above its 5-year average of 4.19, near the high end of its 5-year range (1.62–28.95).
As of the fiscal period ended Tuesday, June 30, 2026. 50.66% above its 12-month average of 16.10.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 24.26.
QUICK RATIO (ACID-TEST)
24.26
QUICK RATIO (ACID-TEST) AVG TTM
16.10
QUICK RATIO (ACID-TEST) AVG 3Y
4.10
QUICK RATIO (ACID-TEST) AVG 5Y
4.19
QUICK RATIO (ACID-TEST) AVG 10Y
4.51
QUICK RATIO (ACID-TEST) AVG 15Y
4.34
QUICK RATIO (ACID-TEST) AVG 20Y
4.40
CURRENT VS TTM AVG
+50.66%
CURRENT VS 3Y AVG
+492.02%
CURRENT VS 5Y AVG
+479.61%
CURRENT VS 10Y AVG
+437.58%
CURRENT VS 15Y AVG
+459.02%
CURRENT VS 20Y AVG
+451.61%
SECTOR MEDIAN · HEALTHCARE
3.25
median of 789 covered companies
CURRENT VS SECTOR MEDIAN
+646.41%
vs the sector median at left
Palisade Bio, Inc.
Market Cap
$261.24M
Quick Ratio (Acid-Test)
24.26
TTM Avg
16.10
3Y Avg
4.10
5Y Avg
4.19
Market Cap
$260.96M
Quick Ratio (Acid-Test)
0.93
TTM Avg
1.36
3Y Avg
5.78
5Y Avg
8.29
Market Cap
$259.85M
Quick Ratio (Acid-Test)
11.02
TTM Avg
6.66
3Y Avg
6.10
5Y Avg
6.28
Market Cap
$262.45M
Quick Ratio (Acid-Test)
13.89
TTM Avg
8.37
3Y Avg
7.38
5Y Avg
15.00
Market Cap
$265.39M
Quick Ratio (Acid-Test)
15.82
TTM Avg
24.04
3Y Avg
14.70
5Y Avg
12.06
Market Cap
$258.09M
Quick Ratio (Acid-Test)
3.19
TTM Avg
3.85
3Y Avg
4.21
5Y Avg
4.14
Market Cap
$265.41M
Quick Ratio (Acid-Test)
7.68
TTM Avg
7.37
3Y Avg
6.66
5Y Avg
5.96
Market Cap
$264.83M
Quick Ratio (Acid-Test)
16.00
TTM Avg
13.11
3Y Avg
8.33
5Y Avg
7.81
Market Cap
$267.03M
Quick Ratio (Acid-Test)
4.46
TTM Avg
8.30
3Y Avg
6.73
5Y Avg
6.78
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palisade Bio, Inc. (PALI) | $261.24M | 24.26 | 16.10 | 4.10 | 4.19 |
| AC Immune S.A. (ACIU)vs › | $260.96M | 0.93 | 1.36 | 5.78 | 8.29 |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $259.85M | 11.02 | 6.66 | 6.10 | 6.28 |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $262.45M | 13.89 | 8.37 | 7.38 | 15.00 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $265.39M | 15.82 | 24.04 | 14.70 | 12.06 |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.09M | 3.19 | 3.85 | 4.21 | 4.14 |
| OraSure Technologies, Inc. (OSUR)vs › | $265.41M | 7.68 | 7.37 | 6.66 | 5.96 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.83M | 16.00 | 13.11 | 8.33 | 7.81 |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.03M | 4.46 | 8.30 | 6.73 | 6.78 |
| Scribe Therapeutics Inc. (SCTX)vs › | $269.11M | N/A | N/A | N/A | N/A |
Quick Ratio
24.26
Excludes inventory
Current Ratio
24.26
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 24.26 |
| 2026-03-31 | 23.71 |
| 2025-12-31 | 28.95 |
| 2025-09-30 | 1.96 |
| 2025-06-30 | 1.62 |
| 2025-03-31 | 2.84 |
| 2024-12-31 | 3.24 |
| 2024-09-30 | 3.34 |
| 2024-06-30 | 4.34 |
| 2024-03-31 | 4.87 |
| 2023-12-31 | 5.15 |
| 2023-09-30 | 6.14 |
| 2023-06-30 | 7.46 |
| 2023-03-31 | 10.88 |
| 2022-12-31 | 4.89 |
| 2022-09-30 | 4.31 |
| 2022-06-30 | 2.59 |
| 2022-03-31 | 4.43 |
| 2021-12-31 | 4.61 |
| 2021-09-30 | 5.51 |
| 2021-06-30 | 3.82 |
| 2021-03-31 | 0.07 |
| 2020-12-31 | 0.11 |
| 2020-09-30 | 0.22 |
| 2020-06-30 | 24.03 |
| 2020-03-31 | 8.82 |
| 2019-12-31 | 4.61 |
| 2019-09-30 | 5.04 |
| 2019-06-30 | 2.53 |
| 2019-03-31 | 3.75 |
| 2018-12-31 | 6.19 |
| 2018-09-30 | 5.49 |
| 2018-06-30 | 10.33 |
| 2018-03-31 | 7.98 |
| 2017-12-31 | 8.22 |
| 2017-09-30 | 8.02 |
| 2017-06-30 | 5.07 |
| 2017-03-31 | 3.40 |
| 2016-12-31 | 2.85 |
| 2016-09-30 | 0.85 |
| 2016-06-30 | 1.37 |
| 2016-03-31 | 1.15 |
| 2015-12-31 | 2.08 |
| 2015-09-30 | 2.62 |
| 2015-06-30 | 4.18 |
| 2015-03-31 | 6.72 |
| 2014-12-31 | 7.03 |
| 2014-09-30 | 4.86 |
| 2014-06-30 | 6.18 |
| 2014-03-31 | 7.30 |
| 2013-12-31 | 2.97 |
| 2013-09-30 | 3.37 |
| 2013-06-30 | 3.98 |
| 2013-03-31 | 5.10 |
| 2012-12-31 | 4.36 |
| 2012-09-30 | 4.80 |
| 2012-06-30 | 1.93 |
| 2012-03-31 | 2.50 |
| 2011-12-31 | 1.24 |
| 2011-09-30 | 2.44 |
| 2011-06-30 | 5.59 |
| 2011-03-31 | 8.45 |
| 2010-12-31 | 3.59 |
| 2010-09-30 | 3.03 |
| 2010-06-30 | 3.65 |
| 2010-03-31 | 2.39 |
| 2009-12-31 | 1.57 |
| 2009-09-30 | 1.10 |
| 2009-06-30 | 1.72 |
| 2009-03-31 | 2.25 |
| 2008-12-31 | 3.98 |
| 2008-09-30 | 4.30 |
| 2008-06-30 | 7.53 |
| 2008-03-31 | 16.97 |
| 2007-12-31 | 7.41 |
| 2007-09-30 | 6.34 |
| 2007-06-30 | 10.46 |
| 2007-03-31 | 13.93 |
| 2006-12-31 | 5.13 |
| 2006-09-30 | 8.99 |
| 2006-06-30 | 0.60 |
